Corient Capital Partners’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$245K Hold
1,122
0.02% 535
2022
Q2
$245K Sell
1,122
-180
-14% -$40.9K 0.02% 550
2022
Q1
$347K Sell
1,302
-5
-0.4% -$1.23K 0.02% 489
2021
Q4
$348K Buy
1,307
+38
+3% +$11K 0.02% 467
2021
Q3
$361K Buy
1,269
+81
+7% +$23.1K 0.03% 445
2021
Q2
$326K Sell
1,188
-1,650
-58% -$449K 0.02% 468
2021
Q1
$740K Buy
2,838
+1,594
+128% +$427K 0.06% 242
2020
Q4
$318K Buy
+1,244
New +$309K 0.03% 366

Other funds holding PODD

Corient Capital Partners's PODD Position: Q3 2022 in Review

Corient Capital Partners held its Insulet (PODD) position steady in Q3 2022 at 1,122 shares worth $245K. The position accounts for 0.02% of the portfolio, ranked #535.

Corient Capital Partners first reported a position in PODD in Q4 2020 and has held it in 8 quarters since. The position peaked at $740K in Q1 2021. 467 funds tracked by Wall St. Rank hold PODD as of Q3 2022.

  • Corient Capital Partners held 1,122 shares of Insulet worth $245K as of Q3 2022.
  • Corient Capital Partners left its Insulet share count unchanged in Q3 2022.
  • Insulet made up 0.02% of Corient Capital Partners's portfolio in Q3 2022, its #535 holding.
  • Corient Capital Partners first reported a position in Insulet in Q4 2020 and has held it in 8 quarters since.
  • Corient Capital Partners's Insulet position peaked at $740K in Q1 2021.
  • 467 funds tracked by Wall St. Rank held Insulet as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.